Sign in to view content

Randomized Trial of PRP vs Intravitreal Ranibizumab Plus Deferred PRP for Proliferative Diabetic Retinopathy

Andrew N. Antoszyk, MD FASRS

Video
Published 2016

Related

Long-term Clinical Impact of Intravitreal anti-VEGF Therapy for Severe Non-proliferative Diabetic Retinopathy (NPDR): Analyses Through a Discrete Event Simulation Model
Jennifer I. Lim, MD, FARVO, FASRS
Updates from the Field
2021
Future Direction of the DRCR Retina Network
Daniel F. Martin, MD
Updates from the Field
2019
Episode 22: Stroke Risk in Patients with CRAO with Dr. Matthew Schrag
Keyvan Koushan, MD, FRCSC
Member Podcasts
2019

Category: Diabetic Retinopathy

See more